| NI n = 50 | LI n = 68 | p value |
---|---|---|---|
Clinical manifestations (N(%)) | |||
 Weakness | 33 (66.00%) | 51 (75.00%) | 0.179 |
 Chest tightness | 20 (40.00%) | 42 (61.76%) | 0.019* |
 Cough and expectoration | 23 (46.00%) | 49 (72.06%) | 0.004* |
 Hemoptysis | 4 (8.00%) | 19 (27.94%) | 0.007* |
 Fever | 8 (16.00%) | 36 (52.94%) | 0.000* |
 Edema | 15 (30.00%) | 26 (38.24%) | 0.353 |
Imaging manifestations (N(%)) | |||
 Interstitial lesions | 15 (30.00%) | 14 (20.59%) | 0.241 |
 Reticular lesion | 15 (30.00%) | 14 (20.59%) | 0.241 |
 Honeycomb lesion | 4 (8.00%) | 2 (2.94%) | 0.216 |
 Alveolar hemorrhage | 1 (2.00%) | 8 (11.76%) | 0.048* |
 Ground glass opacity | 11 (22.00%) | 11 (16.18%) | 0.422 |
 Patchy/banded high-density lesions | 26 (52.00%) | 61 (89.71%) | 0.000* |
 Emphysema/bullae | 16 (32.00%) | 23 (33.82%) | 0.835 |
 Bronchiectasia | 4 (8.00%) | 15 (22.06%) | 0.040* |
 Pulmonary nodule | 22 (44.00%) | 31 (45.59%) | 0.864 |
 Pleural thickening | 24 (48.00%) | 34 (50.00%) | 0.830 |
 Pleural effusion | 10 (20.00%) | 34 (50.00%) | 0.001* |
 Mediastinal lymphadenopathy | 12 (24.00%) | 33 (48.53%) | 0.007* |